loadpatents
Patent applications and USPTO patent grants for Scheer; Mathias.The latest application filed is for "novel dosage form".
Patent | Date |
---|---|
Novel Dosage Form App 20210059944 - Scheer; Mathias ;   et al. | 2021-03-04 |
Controlled release oral dosage form comprising oxycodone Grant 9,387,166 - Rey , et al. July 12, 2 | 2016-07-12 |
Controlled Release Oral Dosage Form Comprising Oxycodone App 20140377349 - Rey; Helene ;   et al. | 2014-12-25 |
Pharmaceutical dosage form Grant 8,709,477 - Kramer , et al. April 29, 2 | 2014-04-29 |
Pharmaceutical Dosage Form App 20120189695 - Kramer; Dirk ;   et al. | 2012-07-26 |
Alfuzosin Tablets And Synthesis App 20110201633 - SCHEER; Mathias ;   et al. | 2011-08-18 |
Pharmaceutical Formulations Comprising Clopidogrel App 20090270448 - Rey; Helene ;   et al. | 2009-10-29 |
Alfuzosin tablets and synthesis App 20060062845 - Scheer; Mathias | 2006-03-23 |
Alfuzosin tablets and synthesis App 20060062846 - Scheer; Mathias ;   et al. | 2006-03-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.